Relationship between striatal levels of interleukin-2 mRNA and plus-maze behaviour in the rat

Neuroscience Letters

Volumn 341, Issue 3, 2003, Pages 205-208

  Pawlak, Cornelius R ^a   Ho, Ying Jui ^b   Schwarting, Rainer K W ^a   Bauhofer, Artur ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anxiety; Cytokines; Interleukin 1; Interleukin 2; Plus maze; Rat behaviour; Striatum

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN TISSUE; CADAVER; CONTROLLED STUDY; CORPUS STRIATUM; MALE; MAZE TEST; MEASUREMENT; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REARING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0345701459     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00184-8     Document Type: Article

References (21)

1. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 461:1999;199-233.
2. Bauhofer A., Witte K., Lemmer B., Middeke M., Lorenz W., Celik I. Quality of life in animals as a new outcome for surgical research: G-CSF as a quality of life improving factor. Eur. Surg. Res. 34:2002;22-29.
3. Brown R.G., Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci. 23:2000;412-417.
4. Connor T.J., Song C., Leonard B.E., Merali Z., Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84:1998;923-933.
5. Cools A.R., Gingras M.A. Nijmegen high and low responders to novelty: a new tool in the search after the neurobiology of drug abuse liability. Pharmacol. Biochem. Behav. 60:1998;151-159.
6. Eizenberg O., Faber-Elman A., Lotan M., Schwartz M. Interleukin-2 transcripts in human and rodent brains: possible expression by astrocytes. J. Neurochem. 64:1995;1928-1936.
7. Graeff F.G., Guimaraes F.S., De Andrade T.G., Deakin J.F. Role of 5-HT in stress, anxiety, and depression. Pharmacol. Biochem. Behav. 54:1996;129-141.
8. Hanisch U.K., Quirion R. Interleukin-2 as a neuroregulatory cytokine. Brain Res. Rev. 21:1995;246-284.
9. Henniger M.S., Ohl F., Holter S.M., Weissenbacher P., Toschi N., Lorscher P., Wigger A., Spanagel R., Landgraf R. Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour. Behav. Brain Res. 111:2000;153-163.
10. Ho Y.-J., Eichendorff J., Schwarting R.K.W. Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav. Brain Res. 136:2002;1-12.
11. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
12. Koh K.B., Lee B.K. Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosom. Med. 60:1998;479-483.
13. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25:2002;154-159.
14. Lacosta S., Merali Z., Anisman H. Influence of acute and repeated interleukin-2 administration on spatial learning, locomotor activity, exploratory behaviors, and anxiety. Behav. Neurosci. 113:1999;1030-1041.
15. Petitto J.M., Huang Z. Molecular cloning of a partial cDNA of the interleukin-2 receptor-beta in normal mouse brain: in situ localization in the hippocampus and expression by neuroblastoma cells. Brain Res. 650:1994;140-145.
16. Plata-Salaman C.R., Ilyin S.E., Turrin N.P., Gayle D., Flynn M.C., Bedard T., Merali Z., Anisman H. Neither acute nor chronic exposure to a naturalistic (predator) stressor influences the interleukin-1beta system, tumor necrosis factor-alpha, transforming growth factor-beta1, and neuropeptide mRNAs in specific brain region. Brain Res. Bull. 51:2000;187-193.
17. Schwarting R.K.W., Thiel C.M., Müller C.P., Huston J.P. Relationship between anxiety and serotonin in the ventral striatum. NeuroReport. 9:1998;1025-1029.
18. Siegling A., Lehmann M., Platzer C., Emmrich F., Volk H.D. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J. Immunol. Methods. 177:1994;23-28.
19. Song C., Merali Z., Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 88:1999;823-836.
20. Walker L.G., Walker M.B., Heys S.D., Lolley J., Wesnes K., Eremin O. The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial. Psycho-Oncology. 6:1997;290-301.
21. Zalcman S.S. Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity. Brain Res. 899:2001;1-9.